title: p38 Mitogen-activated protein kinase regulates nuclear receptor CAR that activates the CYP2B6 gene.
abstract: The constitutive active/androstane receptor (CAR) regulates hepatic drug metabolism by activating genes, such as cytochrome P450, and certain transferases. p38 Mitogen-activated protein kinase (MAPK) is highly activated in human primary hepatocytes but barely in human hepatoma cell lines including HepG2 cells. Liganded-CAR induced CYP2B6 mRNA in human primary hepatocytes far more effectively than in HepG2 cells ectopically expressing CAR. In the present study, we found that activation of p38 MAPK by anisomycin potentiated induction of CYP2B6 mRNA by CAR ligand in HepG2 cells to levels observed in ligand-treated human primary hepatocytes. siRNA knockdown of p38 MAPK abrogated the ability of anisomycin to synergistically induce CYP2B6 mRNA. In addition to CYP2B6, anisomycin cotreatment potentiated an increase in CYP2A7 and CYP2C9 mRNAs but not CYP3A4 or UDP-glucuronosyltransferase 1A1 mRNAs. Thus, activated p38 MAPK is required for liganded-CAR to selectively activate a set of genes that encode drug-metabolizing enzymes. Our present results suggest that CAR-mediated induction of these enzymes cannot be understood by ligand binding alone because the specificity and magnitude of induction are codetermined by a given cell signaling, such as p38 MAPK; both physiologic and pathophysiological states of cell signaling may have a strong impact in hepatic drug-metabolizing capability during treatments.
authors.affiliation: Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA.
authors.forename: Kosuke
authors.initials: K
authors.lastname: Saito
authors.forename: Rick
authors.initials: R
authors.lastname: Moore
authors.forename: Masahiko
authors.initials: M
authors.lastname: Negishi
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics / Q000378:metabolism*; D002478:Cells, Cultured; D000090702:Constitutive Androstane Receptor; D065702:Cytochrome P-450 CYP2B6; D004789:Enzyme Activation / Q000502:physiology; D005260:Female; D056945:Hep G2 Cells; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D008297:Male; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000378:metabolism*; D048051:p38 Mitogen-Activated Protein Kinases / Q000502:physiology*
chemical_list: D000090702:Constitutive Androstane Receptor; D012333:RNA, Messenger; D018160:Receptors, Cytoplasmic and Nuclear; D001189:Aryl Hydrocarbon Hydroxylases; C585599:CYP2B6 protein, human; D065702:Cytochrome P-450 CYP2B6; D048051:p38 Mitogen-Activated Protein Kinases
references.citation: Cancer. 2003 Jun 15;97(12):3017-26
references.pmid: 12784337
references.citation: Mol Cell Biol. 1999 Sep;19(9):6318-22
references.pmid: 10454578
references.citation: J Biol Chem. 2008 Apr 18;283(16):10425-32
references.pmid: 18303024
references.citation: Mol Cell Biol. 2004 Sep;24(18):7931-40
references.pmid: 15340055
references.citation: In Vitro Cell Dev Biol Anim. 1998 Feb;34(2):109-15
references.pmid: 9542647
references.citation: J Biol Chem. 2005 Feb 4;280(5):3458-66
references.pmid: 15563456
references.citation: Crit Care Med. 2000 Apr;28(4 Suppl):N67-77
references.pmid: 10807318
references.citation: Mol Pharmacol. 2007 May;71(5):1217-21
references.pmid: 17314319
references.citation: J Biol Chem. 2006 Sep 8;281(36):26540-51
references.pmid: 16825189
references.citation: Hepatology. 2004 Oct;40(4):951-60
references.pmid: 15382119
references.citation: FEBS Lett. 2005 Jul 4;579(17):3560-4
references.pmid: 15953603
references.citation: Biochem Biophys Res Commun. 1996 Dec 4;229(1):182-8
references.pmid: 8954103
references.citation: Toxicol Lett. 2006 Feb 8;161(1):61-72
references.pmid: 16154717
references.citation: Mol Med Today. 1999 Oct;5(10):439-47
references.pmid: 10498912
references.citation: Drug Metab Dispos. 2005 Jul;33(7):924-9
references.pmid: 15802384
references.citation: FEBS Lett. 2003 Jul 31;548(1-3):17-20
references.pmid: 12885400
references.citation: Mol Cell Biol. 1998 Oct;18(10):5652-8
references.pmid: 9742082
references.citation: J Biol Chem. 2006 Aug 25;281(34):24390-7
references.pmid: 16807249
references.citation: J Biol Chem. 1999 Mar 5;274(10):6043-6
references.pmid: 10037683
references.citation: Hepatology. 2001 May;33(5):1232-8
references.pmid: 11343253